Search

for
Search:

GlossaryIncretin Mimetics

mimic gut hormones to enhance insulin release in diabetes

Incretin mimetics are a class of medications used to treat type 2 diabetes by mimicking the action of incretin hormones, which stimulate insulin release in response to meals. These drugs help lower blood sugar levels by enhancing insulin secretion, slowing gastric emptying, and reducing appetite.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 57 results

research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research The Polycystic Ovary Syndrome: A Position Statement from the European Society of Endocrinology

467 citations , October 2014 in “European Journal of Endocrinology”

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

research Current Possible Treatment Approaches of Polycystic Ovary Syndrome (PCOS)

February 2024 in “Journal of Education, Health and Sport”

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

research Pharmacodynamic Evaluation: Endocrinology

January 2017

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

research Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS

26 citations , December 2020 in “International Journal of Molecular Sciences”

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

View more "incretin mimetics" in research →

Community Join

0 / 0 results

— no results